XML 88 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 54,555 $ 48,367
Adjustments to reconcile net income to net cash used in operating activities, net of acquired businesses:    
Depreciation and amortization 28,543 31,483
Deferred income tax expense 7,970 26,643
(Gain) loss on disposition of assets (2,687) 83
Share-based compensation 4,867 2,541
Non-cash interest expense 4,953 4,853
Decrease (increase) in:    
Receivables, net (62,322) (111,211)
Inventories (80,881) (80,883)
Other current assets (5,965) (38,005)
Increase (decrease) in:    
Accounts payable (30,574) 10,427
Accrued warranties 664 (2,674)
Accrued other liabilities (15,171) 21,660
Income taxes payable 1,607 2,660
Other operating activities (7,959) (18,125)
Net cash used in operating activities (102,400) (102,181)
Cash flows from investing activities:    
Purchases of short-term investments (41,165) (66,938)
Maturities of short-term investments 177,089 92,700
Acquisitions, net of cash received 0 (70,535)
Proceeds from asset dispositions 3,665 5
Capital expenditures (18,960) (23,482)
Other items, net 126 (12)
Net cash provided by (used in) investing activities 120,755 (68,262)
Cash flows from financing activities:    
Net decrease in short-term borrowings (13) (1,343)
Cash dividends to shareholders (10,079) (5,245)
Repurchase of common stock (4,809) 0
Share-based payment arrangements 6,454 (1,287)
Other items, net (2,305) (3,394)
Net cash used in financing activities (10,752) (11,269)
Effect of exchange rate changes on cash 8,976 (23,762)
Net increase (decrease) in cash and cash equivalents 16,579 (205,474)
Cash and cash equivalents at beginning of period 617,356 603,892
Cash and cash equivalents at end of period 633,935 398,418
Supplemental disclosure of cash flow information:    
Interest received, net (60) (6)
Income taxes paid 3,932 8,040
Non-cash investing activities:    
Accrued and contingent acquisition-related liabilities $ 0 $ 28,123